Mania A, Kaczmarek M, Kemnitz P, Figlerowicz M, Sikora J, Sluzewski W, Zeromski J

Language: English
References: 27
Page: 521-529
PDF size: 555.74 Kb.

ABSTRACT

Introduction and aim. Natural Killer (NK) cells play an important role in innate immune response to viral infections and their high proportion is situated in the liver. The aim of this study was to analyze possible relation between the expression of NK cell receptors and varied intensity of liver lesions in chronic hepatitis C (CHC) in children. Material and methods. Study included 105 children with CHC - 54 boys and 51 girls, age 13.62 ± 3.48 years. Blood specimens were taken at the day of the liver biopsy. Histological evaluation was performed according to METAVIR scoring system. Circulating NK cells were evaluated by flow cytometry. The results were shown as a proportion of cells expressing evaluated receptor and its' mean fluorescent intensity (MFI). Results. In 58 children with CHC (55.2%) significant liver fibrosis was observed ( ≥F2). Higher proportion of cells expressing CD158e inhibitory receptors was observed in the group of children with ALT › 2UNL (21.11 ± 14.60 vs. 12.22 ± 8.99%; p = 0.037). While higher proportion of cells expressing inhibitory CD158b receptor was observed in children with significant fibrosis (F ≥ 2) compared to minimal fibrosis (F ‹ 2) - (34.14 ± 12.44 vs. 27.48 ± 8.71%; p = 0.049). Children with advanced fibrosis (F ≥ 3) had higher MFI of NK cell CD 158b receptor than children with fibrosis scored F ‹ 3 - (5344.20 ± 3407.49 vs. 2979.67 ± 1190.64; p = 0.049). Proportion of NK cells expressing CD158b was found a predictor of significant fibrosis in univariate analysis - [OR 1.065; 95%CI (1.07-1.15); p = 0.046]. Conclusions. Higher proportion of NK cells expressing inhibitory CD158b and CD158e receptors is associated with significant liver injury.

REFERENCES

1. Bortolotti F, Verrucchi G, Camma C, Cabibbo G, Zancan L, Indolfi G, Giacchino R, et al. Italian Observatory for HCV Infection and Hepatitis C in Children. Long-term course of chronic hepatitis C in children: from viral clearance to end-stage liver disease. Gastroenterology 2008; 134: 1900-7.

2. Mania A, Kemnitz P, Figlerowicz M, Mazur-Melewska K, Mozer-Lisewska I, Kowala-Piaskowska A, Wo?niak A, et al. Clinical picture and liver histology of chronic hepatitis C in children. Inf Dis Clin Pract 2012; 2: 141-7.

3. European Paediatric Hepatitis C Virus Network. Three broad modalities in the natural history of vertically acquired hepatitis C virus infection. Clin Infect Dis 2005; 41: 45-51.

4. Zeromski J, Mozer-Lisewska I, Kaczmarek M, Kowala-Piaskowska A, Sikora J. NK cells prevalence, subsets and function in viral hepatitis C. Arch Immunol Ther Exp 2011; 59: 449-55.

5. Golden-Mason L, Rosen HR. Natural killer cells: multifaced players with key roles in hepatitis C immunity. Immunol Rev 2013; 255: 68-81.

6. Vilches C, Parham P. KIR: diverse, rapidly evolving receptors of innate and adaptive immunity. Ann Rev Immunol 2002; 20: 217-51.

7. Mondelli MU, Varchetta S, Oliviero B. Natural killer cells in viral hepatitis: facts and controverisies. Eur J Clin Invest 2010; 40: 851-63.

8. Golden-Mason L, Madrigal-Estebas L, McGarth E, Conroy MJ, Ryan EJ, Hegarty JE, O'Farrelly C, et al. Altered natural killer cell subset distributions in resolved and persistent hepatitis C virus infection following single source exposure. Gut 2008; 57: 1121-8.

9. Varchetta S, Mele D, Mantovani S, Oliviero B, Cremonesi E, Ludovisi S, Michelone G, et al. Impaired intrahepatic natural killer cell cytotoxic function in chronic hepatitis C virus infection. Hepatology 2012; 56: 841-9.

10. Ahlestiel G, Titerence RH, Koh C, Edlich B, Feld JJ, Rotman Y, Ghany MG, et al. Natural killer cells are polarized toward cytotoxicity in chronic hepatitis C in interferon-alfa-dependent manner. Gastroenetrology 2010; 138: 325-35.

11. Golden-Mason L, Bambha KM, Cheng L, Howell CD, Taylor MW, Clark PJ, Afdhal N, et al. Virahep-C Study Group. Natural killer inhibitory receptor expression associated with treatment failure and interleukin-28B genotype in patients with chronic hepatitis C. Hepatology 2011; 54: 1559-69.

12. Gardiner C. NK cell function and recepetor diversity in the context of HCV infection. Front Microbiol 2015; 6: 1061-71.

13. Anonymous. Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. The French METAVIR Cooperative Study Group. Hepatology 1994; 20: 15-20.

14. Cesaro S, Bortolotti F, Petris MG, Brugiolo A, Guido M, Carli M. An updated follow-up of chronic hepatitis C after three decades of observation in pediatric patients cured of malignancy. Pediatr. Blood Cancer 2010; 55: 108-112

15. Indolfi G, Mangone G, Moriondo M, Serranti D, Bartolini E, Azzari C, Resti M. Altered natural killer cells subsets distribution in children with hepatitis C following vertical transmission. Aliment Pharmacol Ther 2016; 43: 125-33. doi: 10.1111/apt.13430. Epub 2015 Oct 16.

16. Nakamura I, Asano T, Asabe S, Ando M, Sano T, Miyata Y, Taira J, et al. Restoration of natural killer cell activity by pegylated interferon-alpha/ribavirin therapy in chronic hepatitis C patient. Hepatol Res 2015; 45: 107-12. doi: 10.1111/ hepr.12322.

17. Ahlenstiel G, Edlich B, Hogdal LJ, Rotman Y, Noureddin M, Feld JJ, Holz LE, et al. Early changes in natural killer cell function indicate virologic response to interferon therapy for hepatitis C. Gastroenterology 2011; 141: 1231-9, 1239.e1-2. doi: 10.1053/j.gastro.2011.06.069.

18. Fugier A, Marche H, Thelu MA, Macek Jílková Z, Van Campenhout N, Dufeu-Duchesne T, Leroy V, et al. Functions of liver natural killer cells are dependent on the severity of liver inflammation and fibrosis in chronic hepatitis C. Plos One 2014; 9:doi:10.1371/journal.pone.0095614.

19. Poynard T, Bedossa P, Opolon P. Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups. Lancet 1997; 349: 825-32.

20. Yoon JC, Lim JB, Park JH, Lee JM. Cell-to-cell contact with hepatitis C virus-infected cells reduces functional capacity of natural killer cells. J Virol 2011; 85: 12557-69.

21. Romero V, Azocar J, Zúńiga J, Clavijo OP, Terreros D, Gu X, Husain Z, et al. Interaction of NK inhibitory receptor genes with HLA-C and MHC class II alleles in Hepatitis C virus infection outcome. Mol Immunol 2008; 45: 2429-36.

22. Konjevic G, Mirjacic Martinovic K, Vuletic A, Babovic N. Novel aspects of in vitro IL-2 or IFN-alpha enhanced NK cytotoxicity of healthy individuals based on NKG2D and CD161 NK cell receptor induction. Biomed Pharmacother 2010; 64: 663-71.

23. Kremer M, Hines IN, Milton RJ, Wheeler MD. Favored T helper 1 response in a mouse model of hepatosteatosis is associated with enhanced T cell-mediated hepatitis. Hepatology 2006; 44: 216-27.

24. Mania A, Kaczmarek M, Kemnitz P, Mozer-Lisewska I, Figlerowicz F, Wo?niak A, Mazur-Melewska K, et al. Alterations in NK cell phenotype in relation to liver steatosis in children with chronic hepatitis C. Inflammation 2013; 36: 1004-12.

25. Alter G, Jost S, Rihn S, Reyor LL, Nolan BE, Ghebremichael M, Bosch R, et al. Reduced frequencies of NKp30+NKp46+, CD161+, and NKG2D+ NK cells in acute HCV infection may predict viral clearance. J Hepatol 2011; 55: 278-88.

26. Mondelli MU, Oliviero B, Mele D, Mantovani S, Gazzabin C, Varchetta S. Natural killer cell functional dichotomy: a feature of chronic viral hepatitis. Front Immunol 2012; 3: 351.

27. Jaeger BN, Donadieu J, Cognet C, Bernat C, Ordońez-Rueda D, Barlogis V, Mahlaoui N, et al. Neutrophil depletion impairs natural killer cell maturation, function and homeostatis. J Exp Med 2012; 209: 565-80.